US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
JPH0742304B2
(ja)
|
1986-12-05 |
1995-05-10 |
財団法人微生物化学研究会 |
新規なアンスラサイクリン誘導体およびその製造法
|
DE3883899T3
(de)
|
1987-03-18 |
1999-04-22 |
Sb2 Inc |
Geänderte antikörper.
|
DE3712350A1
(de)
|
1987-04-11 |
1988-10-20 |
Behringwerke Ag |
Semisynthetische rhodomycine, verfahren zu ihrer herstellung und ihre verwendung als zytostatika
|
EP0335369A3
(en)
|
1988-03-29 |
1990-03-28 |
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai |
New anthracycline derivatives and processes for the preparation of the same
|
US5047335A
(en)
|
1988-12-21 |
1991-09-10 |
The Regents Of The University Of Calif. |
Process for controlling intracellular glycosylation of proteins
|
EP0479909B1
(en)
|
1989-06-29 |
1996-10-30 |
Medarex, Inc. |
Bispecific reagents for aids therapy
|
AP340A
(en)
|
1990-06-11 |
1994-05-13 |
Iaf Biochem Int |
Heterocyclic anathracyclinone and anathracycline analogs
|
AU8295491A
(en)
|
1990-06-29 |
1992-01-23 |
Biosource Technologies Incorporated |
Melanin production by transformed microorganisms
|
MY106399A
(en)
|
1990-07-24 |
1995-05-30 |
Pfizer |
Cephalosporins and homologeus, preparation and pharmaceutical composition
|
US5192880A
(en)
|
1990-11-13 |
1993-03-09 |
Nec Corporation |
High-speed emitter coupled logic circuit with large current driving capability
|
KR100211417B1
(ko)
|
1990-11-30 |
1999-10-01 |
유충식 |
L-탈로피라노시드 유도체 및 그의 제조방법
|
US5571894A
(en)
|
1991-02-05 |
1996-11-05 |
Ciba-Geigy Corporation |
Recombinant antibodies specific for a growth factor receptor
|
NZ241606A
(en)
|
1991-02-28 |
1994-08-26 |
Iaf Biochem Int |
Heteroanthracycline antitumor analogs, preparation and pharmaceutical compositions thereof; intermediates therefor
|
JP3025056B2
(ja)
|
1991-03-12 |
2000-03-27 |
財団法人微生物化学研究会 |
2,6−ジデオキシ−2−フルオロ−l−タロピラノース誘導体の製造法
|
US5278299A
(en)
|
1991-03-18 |
1994-01-11 |
Scripps Clinic And Research Foundation |
Method and composition for synthesizing sialylated glycosyl compounds
|
JPH04290891A
(ja)
|
1991-03-19 |
1992-10-15 |
Yasumitsu Tamura |
新規なアンスラサイクリン系化合物
|
DE4111971C1
(he)
|
1991-04-12 |
1992-03-12 |
Wolf-Dieter Dr. 7803 Gundelfingen De Fessner |
|
US5552534A
(en)
|
1991-08-22 |
1996-09-03 |
The Trustees Of The University Of Pennsylvania |
Non-Peptide peptidomimetics
|
US5587458A
(en)
|
1991-10-07 |
1996-12-24 |
Aronex Pharmaceuticals, Inc. |
Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
|
JPH07500248A
(ja)
|
1991-10-15 |
1995-01-12 |
ザ スクリップス リサーチ インスティテュート |
糖ヌクレオチドの酵素的フコシル化合成によるフコシル化炭水化物の生産、及びGDP−フコースのin situ 再生
|
WO1993008829A1
(en)
|
1991-11-04 |
1993-05-13 |
The Regents Of The University Of California |
Compositions that mediate killing of hiv-infected cells
|
AU3144193A
(en)
|
1991-11-21 |
1993-06-15 |
Board Of Trustees Of The Leland Stanford Junior University |
Controlling degradation of glycoprotein oligosaccharides by extracellular glycosisases
|
DE69334255D1
(de)
|
1992-02-06 |
2009-02-12 |
Novartis Vaccines & Diagnostic |
Marker für Krebs und biosynthetisches Bindeprotein dafür
|
US5278311A
(en)
|
1992-06-05 |
1994-01-11 |
E. R. Squibb & Sons, Inc. |
Nonionic radiographic contrast agents
|
US5736523A
(en)
|
1992-11-09 |
1998-04-07 |
Biochem Pharma Inc. |
Antineoplastic heteronapthoquinones
|
DK76193D0
(da)
|
1993-06-25 |
1993-06-25 |
Astra Ab |
Kulhydratderivater
|
US5670315A
(en)
|
1993-09-13 |
1997-09-23 |
Canon Kabushiki Kaisha |
Nucleic acid determination employing pyryilium dye
|
GB9418260D0
(en)
|
1994-09-09 |
1994-10-26 |
Erba Carlo Spa |
Anthracycline derivatives
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
JPH08286368A
(ja)
|
1995-04-14 |
1996-11-01 |
Toyo Ink Mfg Co Ltd |
着色画像形成材料およびそれを用いた着色画像形成媒体と着色画像形成方法
|
US6245347B1
(en)
|
1995-07-28 |
2001-06-12 |
Zars, Inc. |
Methods and apparatus for improved administration of pharmaceutically active compounds
|
CA2184956A1
(en)
|
1995-09-08 |
1997-03-09 |
Tomio Takeuchi |
Fluorine-containing anthracycline derivatives having hydroxyl group(s) mono- or di-o-aminoalkanoylated in the sugar moiety thereof
|
DE19541260A1
(de)
|
1995-11-06 |
1997-05-07 |
Lohmann Therapie Syst Lts |
Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut
|
US5834597A
(en)
|
1996-05-20 |
1998-11-10 |
Protein Design Labs, Inc. |
Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
|
US6512010B1
(en)
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
PL182601B1
(pl)
|
1996-07-17 |
2002-02-28 |
Waldpharm Sp Z Oo |
Sposób otrzymywania antybiotyków antracyklinowych
|
DE19640969A1
(de)
|
1996-10-04 |
1998-04-16 |
Bayer Ag |
20-0-verknüpfte Glycokonjugate von Camptothecin
|
US5770407A
(en)
|
1996-12-10 |
1998-06-23 |
The Scripps Research Institute |
Process for preparing nucleotide inhibitors of glycosyltransferases
|
FR2764304B1
(fr)
|
1997-06-06 |
1999-07-16 |
Rhone Poulenc Rorer Sa |
Nouvelle classe d'agents transfectants cationiques des acides nucleiques
|
JPH1135593A
(ja)
|
1997-07-18 |
1999-02-09 |
Daikin Ind Ltd |
2−フルオロフコシル−n−アロイルグルコサミン誘導体及びその中間物、並びにそれらの製造方法
|
US6248864B1
(en)
|
1997-12-31 |
2001-06-19 |
Adherex Technologies, Inc. |
Compounds and methods and modulating tissue permeability
|
DK2180007T4
(da)
|
1998-04-20 |
2017-11-27 |
Roche Glycart Ag |
Glycosyleringsteknik for antistoffer til forbedring af antistofafhængig cellecytotoxicitet
|
US6312717B1
(en)
|
1998-07-07 |
2001-11-06 |
Bristol-Myers Squibb Company |
Method for treatment of anxiety and depression
|
SE9802864D0
(sv)
|
1998-08-27 |
1998-08-27 |
Pharmacia & Upjohn Ab |
Transdermally administered tolterodine as antimuscarinic agent for the treatment of overactive bladder
|
KR100483832B1
(ko)
|
1999-02-05 |
2005-04-20 |
삼성전자주식회사 |
영상 텍스쳐 기술자 추출 방법
|
PT1176195E
(pt)
|
1999-04-09 |
2013-07-18 |
Kyowa Hakko Kirin Co Ltd |
Processo para controlar a actividade de uma molécula funcional sob o ponto de vista imunológico
|
US6544548B1
(en)
|
1999-09-13 |
2003-04-08 |
Keraplast Technologies, Ltd. |
Keratin-based powders and hydrogel for pharmaceutical applications
|
US20080050809A1
(en)
|
1999-09-28 |
2008-02-28 |
Alejandro Abuin |
Novel human kinases and polynucleotides encoding the same
|
US20040219521A1
(en)
|
2000-01-21 |
2004-11-04 |
Tang Y. Tom |
Novel nucleic acids and polypeptides
|
FR2807767B1
(fr)
|
2000-04-12 |
2005-01-14 |
Lab Francais Du Fractionnement |
Anticorps monoclonaux anti-d
|
US6589549B2
(en)
|
2000-04-27 |
2003-07-08 |
Macromed, Incorporated |
Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
|
US6670330B1
(en)
|
2000-05-01 |
2003-12-30 |
Theodore J. Lampidis |
Cancer chemotherapy with 2-deoxy-D-glucose
|
US6696081B2
(en)
|
2000-06-09 |
2004-02-24 |
Duke University |
Carbohydrate based lipid compositions and supramolecular structures comprising same
|
AU2001281886A1
(en)
|
2000-06-26 |
2002-01-08 |
Basf Aktiengesellschaft |
Phosphacyclohexanes and the use thereof in the hydroformylation of olefins
|
US6946292B2
(en)
|
2000-10-06 |
2005-09-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Cells producing antibody compositions with increased antibody dependent cytotoxic activity
|
MXPA04001072A
(es)
|
2001-08-03 |
2005-02-17 |
Glycart Biotechnology Ag |
Variantes de glicosilacion de anticuerpos que tienen citotoxicidad celulares dependiente de anticuerpos incrementada.
|
EP1504099A4
(en)
|
2001-12-10 |
2006-05-10 |
Nuvelo Inc |
NEW NUCLEIC ACIDS AND POLYPEPTIDES
|
AU2003211112A1
(en)
|
2002-02-13 |
2003-09-04 |
Incyte Corporation |
Secreted proteins
|
CA2476518A1
(en)
|
2002-02-22 |
2003-09-04 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
US7193069B2
(en)
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
AUPS247502A0
(en)
|
2002-05-22 |
2002-06-13 |
Griffith University |
An antimicrobial agent
|
CA2497334A1
(en)
|
2002-09-11 |
2004-03-25 |
Genentech, Inc. |
Novel compositions and methods for the treatment of immune related diseases
|
EP1539228B1
(en)
|
2002-09-11 |
2010-12-29 |
Genentech, Inc. |
Novel composition and methods for the treatment of immune related diseases
|
US7074826B2
(en)
|
2002-10-07 |
2006-07-11 |
Encore Pharmaceuticals, Inc. |
R-NSAID esters and their use
|
DE602004027888D1
(de)
|
2003-02-20 |
2010-08-12 |
Seattle Genetics Inc |
Anti-cd70 antikörper-arzneimittelkonjugate und ihr
|
EP1613261A4
(en)
|
2003-04-09 |
2011-01-26 |
Novo Nordisk As |
INTRA-CELLULAR FORMATION OF PEPTIDE CONJUGATES
|
CN1835962A
(zh)
|
2003-06-03 |
2006-09-20 |
加利福尼亚大学董事会 |
利用乙酰化二糖治疗疾病的组合物与方法
|
FR2858235B1
(fr)
|
2003-07-31 |
2006-02-17 |
Lab Francais Du Fractionnement |
Utilisation d'anticorps optimises en adcc pour traiter les patients faibles repondeurs
|
WO2005049562A2
(en)
|
2003-11-17 |
2005-06-02 |
Aromagen Corporation |
Novel cyclic oxygenated compounds having cooling, fragrance, and flavor properties, and uses thereof
|
RU2006126718A
(ru)
|
2003-12-23 |
2008-01-27 |
Проджен Индастриз Лимитед (Au) |
Миметики гликозаминогликанов (gag)
|
PL369253A1
(pl)
|
2004-07-23 |
2006-02-06 |
Zakład Badawczo-Produkcyjny SYNTEX Sp.z o.o. |
Sposób otrzymywania złożonych 2-deoksy-2-jodopiranozydów o wysokiej czystości, szczególnie Annamycyny o czystości farmaceutycznej
|
SG190665A1
(en)
|
2004-07-30 |
2013-06-28 |
Rinat Neuroscience Corp |
Antibodies directed against amyloid-beta peptide and methods using same
|
JP2008516938A
(ja)
|
2004-10-15 |
2008-05-22 |
アストラゼネカ アクチボラグ |
置換アデニンとその使用
|
CA2587766A1
(en)
|
2004-11-10 |
2007-03-01 |
Macrogenics, Inc. |
Engineering fc antibody regions to confer effector function
|
WO2006124667A2
(en)
|
2005-05-12 |
2006-11-23 |
Zymogenetics, Inc. |
Compositions and methods for modulating immune responses
|
RU2407544C2
(ru)
|
2005-05-26 |
2010-12-27 |
Сиэтл Дженетикс, Инк. |
Гуманизированные анти-cd40-антитела и способы их применения
|
EP1963534A2
(en)
|
2005-12-19 |
2008-09-03 |
Genizon Biosciences Inc. |
Genemap of the human gene associated with crohn's disease
|
CA2643038A1
(en)
|
2006-02-24 |
2007-09-07 |
Board Of Regents, The University Of Texas System |
Hexose compounds to treat cancer
|
CA2642189A1
(en)
|
2006-02-24 |
2007-09-07 |
University Of Miami |
Mannose derivatives for killing tumor cells
|
WO2007124283A2
(en)
|
2006-04-13 |
2007-11-01 |
Zymogenetics, Inc. |
Tetramerizing polypeptides and methods of use
|
US20100075377A1
(en)
|
2006-04-13 |
2010-03-25 |
West James W |
Tetramerizing polypeptides and methods of use
|
US9149489B2
(en)
|
2006-04-27 |
2015-10-06 |
Board Of Regents, University Of Texas System |
Inhibitors of glycolysis useful in the treatment of brain tumors
|
EP2520935A3
(en)
|
2006-08-09 |
2013-02-13 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
DE102006053637B4
(de)
|
2006-11-14 |
2011-06-30 |
Sanofi-Aventis Deutschland GmbH, 65929 |
Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
DE102006053635B4
(de)
|
2006-11-14 |
2011-06-30 |
Sanofi-Aventis Deutschland GmbH, 65929 |
Neue mit Benzylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
EP2609932B1
(en)
|
2006-12-01 |
2022-02-02 |
Seagen Inc. |
Variant target binding agents and uses thereof
|
WO2008131024A1
(en)
|
2007-04-17 |
2008-10-30 |
Board Of Regents, The University Of Texas System |
Iodo-hexose compounds useful to treat cancer
|
GB0714514D0
(en)
*
|
2007-07-26 |
2007-09-05 |
Univ City |
Computer system
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
CA2964398C
(en)
|
2007-09-14 |
2023-03-07 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
ES2629440T5
(es)
|
2007-10-04 |
2020-11-20 |
Zymogenetics Inc |
zB7H6 miembro de la familia B7 y composiciones y métodos relacionados
|
US8293720B2
(en)
|
2007-12-20 |
2012-10-23 |
Dogwood Pharmaceuticals, Inc. |
Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
|
EP2247603B1
(en)
|
2008-02-12 |
2016-09-28 |
Dow AgroSciences LLC |
Pesticidal compositions
|
JP5260093B2
(ja)
|
2008-03-10 |
2013-08-14 |
クラレノリタケデンタル株式会社 |
重合性単量体、重合性組成物及び歯科用材料
|
JP5501339B2
(ja)
|
2008-03-21 |
2014-05-21 |
ザ ジェネラル ホスピタル コーポレイション |
アルツハイマー病及び関連疾患の検出及び治療のための化合物及び組成物
|
CN101555262A
(zh)
|
2008-04-08 |
2009-10-14 |
中国科学院生态环境研究中心 |
六水合三氯化铁(FeCl3·6H2O)选择性脱除糖类化合物异头碳酰基的方法
|
US20090258013A1
(en)
|
2008-04-09 |
2009-10-15 |
Genentech, Inc. |
Novel compositions and methods for the treatment of immune related diseases
|
CA2975228C
(en)
|
2008-05-02 |
2020-07-21 |
Seattle Genetics, Inc. |
Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
|
WO2009143515A2
(en)
|
2008-05-23 |
2009-11-26 |
University Of Miami |
Treatment using continuous low dose application of sugar analogs
|
NZ594290A
(en)
|
2009-02-11 |
2012-09-28 |
Dow Agrosciences Llc |
Pyranose derived pesticidal compositions
|
US20120064100A1
(en)
|
2009-03-18 |
2012-03-15 |
Simon Barry |
Biomarkers and uses thereof
|
WO2010111713A2
(en)
|
2009-03-27 |
2010-09-30 |
Zacharon Pharmaceuticals, Inc. |
N-linked glycan biosynthesis modulators
|
WO2010122460A1
(en)
|
2009-04-20 |
2010-10-28 |
Pfizer Inc. |
Control of protein glycosylation and compositions and methods relating thereto
|
US9624255B2
(en)
|
2009-08-11 |
2017-04-18 |
Arizona Board Of Regents |
Carbohydrate-mediated tumor targeting
|
US9198972B2
(en)
|
2010-01-28 |
2015-12-01 |
Alnylam Pharmaceuticals, Inc. |
Monomers and oligonucleotides comprising cycloaddition adduct(s)
|
WO2011137528A1
(en)
|
2010-05-06 |
2011-11-10 |
Simon Fraser University |
Methods and compounds for inhibiting glycosyltransferases
|
EP2580238A1
(en)
|
2010-06-09 |
2013-04-17 |
Zymogenetics, Inc. |
Dimeric vstm3 fusion proteins and related compositions and methods
|
DK3336225T3
(da)
|
2010-07-16 |
2020-03-30 |
Adimab Llc |
Antistofbiblioteker
|
US9504702B2
(en)
|
2010-08-05 |
2016-11-29 |
Seattle Genetics, Inc. |
Methods of inhibition of protein fucosylation in vivo using fucose analogs
|
EP2603595A1
(en)
|
2010-08-12 |
2013-06-19 |
Novozymes, Inc. |
Compositions comprising a polypeptide having cellulolytic enhancing activity and a dioxy compound and uses thereof
|
TWI410431B
(zh)
|
2010-12-22 |
2013-10-01 |
Ind Tech Res Inst |
齊敦果酸衍生物在製備預防或治療c型肝炎之藥物的用途
|
US8923278B2
(en)
|
2011-01-10 |
2014-12-30 |
Vtech Telecommunications Limited |
Peer-to-peer, internet protocol telephone system with system-wide configuration data
|
JP2014505058A
(ja)
|
2011-01-11 |
2014-02-27 |
ザ・ユニバーシティ・オブ・テキサス・エム・ディー・アンダーソン・キャンサー |
増殖性および炎症性皮膚疾患の治療用単糖ベース化合物
|
US9493452B2
(en)
|
2011-03-24 |
2016-11-15 |
Southern Methodist University |
Compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as raf kinase and LRRK2 inhibitors
|
CN103582647A
(zh)
|
2011-05-31 |
2014-02-12 |
默克专利股份有限公司 |
含有氢基-三氰基-硼酸根阴离子的化合物
|
US9058935B2
(en)
|
2011-07-15 |
2015-06-16 |
Merc Patent Gmbh |
Compounds containing alkyl-cyano-borate or alkyl-cyano-fluoroborate anions
|
WO2013068874A1
(en)
|
2011-11-11 |
2013-05-16 |
Pfizer Inc. |
Antibody-drug conjugates
|
CA2867129C
(en)
|
2012-03-13 |
2023-11-21 |
Salk Institute For Biological Studies |
Selective cell targeting using adenovirus and chemical dimers
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
AU2013243951A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of secreted proteins
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
EP3903820A1
(en)
|
2012-05-25 |
2021-11-03 |
Sloan-Kettering Institute for Cancer Research |
An anti-ceramide antibodies
|
AU2013271515A1
(en)
|
2012-06-06 |
2015-01-15 |
Oncomed Pharmaceuticals, Inc. |
Binding agents that modulate the Hippo pathway and uses thereof
|
EP2925350B1
(en)
|
2012-12-03 |
2019-01-30 |
Bristol-Myers Squibb Company |
Enhancing anti-cancer activity of immunomodulatory fc fusion proteins
|
AU2013355379B2
(en)
|
2012-12-04 |
2018-08-09 |
Oncomed Pharmaceuticals, Inc. |
Immunotherapy with binding agents
|
CN104250302B
(zh)
|
2013-06-26 |
2017-11-14 |
上海君实生物医药科技股份有限公司 |
抗pd‑1抗体及其应用
|
RS60826B1
(sr)
|
2013-07-16 |
2020-10-30 |
Hoffmann La Roche |
Postupci lečenja kancera upotrebom antagonista vezivanja pd-1 ose i tigit inhibitora
|
US10077305B2
(en)
|
2013-09-10 |
2018-09-18 |
Medimmune Limited |
Antibodies against PD-1 and uses thereof
|
EP3060581A4
(en)
|
2013-10-25 |
2017-06-07 |
Dana-Farber Cancer Institute, Inc. |
Anti-pd-l1 monoclonal antibodies and fragments thereof
|
US20150132744A1
(en)
|
2013-11-13 |
2015-05-14 |
Oregon Health And Science University |
Methods of detecting cells latently infected with hiv
|
ES2920677T3
(es)
*
|
2013-12-24 |
2022-08-08 |
Janssen Pharmaceutica Nv |
Anticuerpos y fragmentos anti-VISTA
|
EP3119913B1
(en)
|
2014-03-21 |
2021-01-06 |
The Brigham and Women's Hospital, Inc. |
Methods and compositions for treatment of immune-related diseases or disorders and/or therapy monitoring
|
KR20170023081A
(ko)
|
2014-07-16 |
2017-03-02 |
제넨테크, 인크. |
Tigit 억제제 및 항암제를 사용한 암 치료 방법
|
JP6920194B2
(ja)
|
2014-08-19 |
2021-08-18 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
抗tigit抗体
|
AU2015339128C1
(en)
|
2014-10-29 |
2021-12-16 |
Seagen Inc. |
Dosage and administration of non-fucosylated anti-CD40 antibodies
|
US20190119353A1
(en)
|
2014-11-06 |
2019-04-25 |
Children's Research Institute, Children's National Medical Center |
Immunotherapeutics for cancer and autoimmune diseases
|
WO2016073879A2
(en)
|
2014-11-06 |
2016-05-12 |
Scholar Rock, Inc. |
Transforming growth factor-related antibodies and uses thereof
|
US20160152720A1
(en)
|
2014-11-06 |
2016-06-02 |
Genentech, Inc. |
Combination therapy comprising ox40 binding agonists and tigit inhibitors
|
ES2905615T3
(es)
|
2014-11-20 |
2022-04-11 |
Promega Corp |
Sistemas y métodos para evaluar moduladores de puntos de control inmunitario
|
TWI595006B
(zh)
|
2014-12-09 |
2017-08-11 |
禮納特神經系統科學公司 |
抗pd-1抗體類和使用彼等之方法
|
DK3237446T3
(en)
|
2014-12-22 |
2021-07-26 |
Pd 1 Acquisition Group Llc |
Anti-PD-1-antistoffer
|
MA40662B1
(fr)
|
2014-12-23 |
2020-12-31 |
Bristol Myers Squibb Co |
Anticorps contre tigit
|
US20170369570A1
(en)
|
2015-01-20 |
2017-12-28 |
Immunexcite, Inc. |
Compositions and methods for cancer immunotherapy
|
WO2016134333A1
(en)
|
2015-02-19 |
2016-08-25 |
Compugen Ltd. |
Anti-pvrig antibodies and methods of use
|
DK3259597T3
(da)
|
2015-02-19 |
2022-05-09 |
Compugen Ltd |
Pvrig-polypeptider og fremgangsmåder til behandling
|
WO2016166139A1
(en)
|
2015-04-14 |
2016-10-20 |
Eberhard Karls Universität Tübingen |
Bispecific fusion proteins for enhancing immune responses of lymphocytes against tumor cells
|
JP2018512856A
(ja)
|
2015-04-17 |
2018-05-24 |
アルパイン イミューン サイエンシズ インコーポレイテッド |
調整可能な親和性を有する免疫調節タンパク質
|
WO2016179288A1
(en)
|
2015-05-04 |
2016-11-10 |
University Of Florida Research Foundation, Inc. |
Novel regulatory-cells, method for their isolation and uses
|
TWI715587B
(zh)
|
2015-05-28 |
2021-01-11 |
美商安可美德藥物股份有限公司 |
Tigit結合劑和彼之用途
|
WO2016196389A1
(en)
|
2015-05-29 |
2016-12-08 |
Bristol-Myers Squibb Company |
Treatment of renal cell carcinoma
|
EP3302548A4
(en)
|
2015-06-03 |
2019-01-02 |
Dana Farber Cancer Institute, Inc. |
Methods to induce conversion of regulatory t cells into effector t cells for cancer immunotherapy
|
JO3620B1
(ar)
|
2015-08-05 |
2020-08-27 |
Amgen Res Munich Gmbh |
مثبطات نقطة فحص مناعية للاستخدام في علاج سرطانات محمولة عبر الدم
|
AU2016307845B2
(en)
|
2015-08-14 |
2020-10-15 |
Merck Sharp & Dohme Llc |
Anti-TIGIT antibodies
|
US20180244783A1
(en)
|
2015-08-31 |
2018-08-30 |
Oncomed Pharmaceuticals, Inc. |
Combination therapy for treatment of disease
|
WO2017040660A1
(en)
|
2015-08-31 |
2017-03-09 |
Oncomed Pharmaceuticals, Inc. |
Combination therapy for treatment of disease
|
CN108137691B
(zh)
|
2015-09-02 |
2021-10-19 |
耶路撒冷希伯来大学伊萨姆研究发展有限公司 |
特异性针对人类t-细胞免疫球蛋白和itim结构域(tigit)的抗体
|
US11242375B2
(en)
|
2015-09-04 |
2022-02-08 |
Memorial Sloan Kettering Cancer Center |
Immune cell compositions and methods of use
|
US20180256644A1
(en)
|
2015-09-14 |
2018-09-13 |
Alpine Immune Sciences, Inc. |
Tunable variant immunoglobulin superfamily domains and engineered cell therapy
|
CA2998589A1
(en)
|
2015-09-14 |
2017-03-23 |
Compass Therapeutics Llc |
Compositions and methods for treating cancer via antagonism of the cd155/tigit pathway and tgf-.beta.
|
RU2732591C2
(ru)
|
2015-09-25 |
2020-09-21 |
Дженентек, Инк. |
Анти-tigit антитела и способы применения
|
CN108368176B
(zh)
|
2015-10-01 |
2022-06-07 |
波滕扎治疗公司 |
抗tigit抗原结合蛋白及其使用方法
|
SG10201913576RA
(en)
|
2015-10-01 |
2020-02-27 |
Heat Biologics Inc |
Compositions and methods for adjoining type i and type ii extracellular domains as heterologous chimeric proteins
|
PL3370768T3
(pl)
|
2015-11-03 |
2022-06-13 |
Janssen Biotech, Inc. |
Przeciwciała specyficznie wiążące pd-1 i ich zastosowania
|
CN108289903B
(zh)
|
2015-12-04 |
2021-08-03 |
西雅图基因公司 |
与检验点抑制剂联合使用2-脱氧-2-氟-l-岩藻糖的癌症治疗
|
WO2017100428A1
(en)
|
2015-12-09 |
2017-06-15 |
Memorial Sloan Kettering Cancer Center |
Immune cell compositions and methods of using same
|
WO2017149538A1
(en)
|
2016-03-01 |
2017-09-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Antibodies specific to human poliovirus receptor (pvr)
|
KR102588359B1
(ko)
|
2016-03-04 |
2023-10-13 |
제이엔 바이오사이언시즈 엘엘씨 |
Tigit에 대한 항체
|
US11446398B2
(en)
|
2016-04-11 |
2022-09-20 |
Obsidian Therapeutics, Inc. |
Regulated biocircuit systems
|
MA43552A
(fr)
|
2016-04-15 |
2018-11-07 |
Alpine Immune Sciences Inc |
Protéines immunomodulatrices à variants de cd80 et leurs utilisations
|
CA3019199A1
(en)
|
2016-04-15 |
2017-10-19 |
Alpine Immune Sciences, Inc. |
Icos ligand variant immunomodulatory proteins and uses thereof
|
WO2017191274A2
(en)
|
2016-05-04 |
2017-11-09 |
Curevac Ag |
Rna encoding a therapeutic protein
|
US11400116B2
(en)
|
2016-05-06 |
2022-08-02 |
The Regents Of The University Of California |
Systems and methods for targeting cancer cells
|
CA3023980A1
(en)
|
2016-05-16 |
2017-11-23 |
Checkmab S.R.L. |
Markers selectively deregulated in tumor-infiltrating regulatory t cells
|
JP7261379B2
(ja)
|
2016-06-20 |
2023-04-20 |
カイマブ・リミテッド |
抗pd-l1抗体
|
CN110088127A
(zh)
|
2016-07-28 |
2019-08-02 |
高山免疫科学股份有限公司 |
Cd155变体免疫调节蛋白及其用途
|
WO2018022945A1
(en)
|
2016-07-28 |
2018-02-01 |
Alpine Immune Sciences, Inc. |
Cd112 variant immunomodulatory proteins and uses thereof
|
EP3347379B9
(en)
|
2016-08-17 |
2020-03-25 |
Compugen Ltd. |
Anti-tigit antibodies, anti-pvrig antibodies and combinations thereof
|
AU2017319151B2
(en)
|
2016-08-30 |
2024-01-11 |
Memorial Sloan Kettering Cancer Center |
Immune cell compositions and methods of use for treating viral and other infections
|
WO2018041120A1
(en)
|
2016-08-31 |
2018-03-08 |
Beijing Biocytogen Co., Ltd |
Genetically modified non-human animal with human or chimeric tigit
|
IL300982B1
(he)
|
2016-09-10 |
2024-04-01 |
Yeda Res & Dev |
הפחתה של רמת תאי ה t הרגולטוריים או פעילותם לשם טיפול במחלות ונזקים במערכת העצבים המרכזית
|
EP3293271A1
(en)
|
2016-09-12 |
2018-03-14 |
The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin |
Marker and target as a diagnostic variable and target for therapy of metastatic cancer
|
US20190225701A1
(en)
|
2016-09-26 |
2019-07-25 |
The Brigham And Women's Hospital, Inc. |
Regulators of b cell-mediated immunosuppression
|
US10759855B2
(en)
|
2016-12-02 |
2020-09-01 |
Rigel Pharmaceuticals, Inc. |
Antigen binding molecules to TIGIT
|
CN111050788A
(zh)
*
|
2017-02-28 |
2020-04-21 |
西雅图基因公司 |
抗tigit抗体
|
JOP20190203A1
(ar)
|
2017-03-30 |
2019-09-03 |
Potenza Therapeutics Inc |
بروتينات رابطة لمولد ضد مضادة لـ tigit وطرق استخدامها
|